Global patterns and trends in brain and central nervous system tumor incidence by histological subtype in 185 countries in 2022: a population-based study
The global landscape of cancer burden attributable to tobacco smoking in 2022: a population-based systematic analysis
Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022.
Global variations and socioeconomic inequalities in lifetime risk of lip, oral cavity, and pharyngeal cancer: a population-based systematic analysis of GLOBOCAN 2022.
Lifetime probabilities of developing and dying from cancer in China: comparison with Japan and the United States in 2022.
Global disparities in healthcare resources and cancer burden: a population-based systematic analysis of 171 countries in 2022.
Cervical cancer burden and trends in China, 2000-2020: Asia-Pacific international comparisons and insights for elimination goals.
Global patterns and trends in cancer-related premature death and their impact on life expectancy across 185 countries: a population-based analysis.
Long-term exposure to ozone and incidence of lung cancer in China: data based on a national population cohort (ChinaHEART).
Temporal Trends and Sex Differences in the Incidence of Esophageal Squamous Cell Carcinoma and Adenocarcinoma from CI5 VIII-XII Data - Global, 1993-2017.
Rare tumor list provide vast opportunities for novel drug development in China.
Risk assessment of persistent incidental pulmonary subsolid nodules to guide appropriate surveillance interval and endpoints.
Global, regional, national incidence, and mortality of breast cancer in older women: A population-based cancer registry data analysis.
The practice and cost-effectiveness of opportunistic endoscopic screening for upper gastrointestinal tract cancer: a real-world study in China
Secondary Cytoreductive Surgery for Ovarian Cancer With Second Platinum-Sensitive Recurrence: A Multicentre Retrospective Cohort Study.
Trends in the Incidence, Mortality and Lifetime Risks of Female Breast and Cervical Cancer - Guangdong Province, China, 2023.
Assessment of the participation rate and effectiveness of upper gastrointestinal cancer screening in China: a multicenter population-based screening study.
Data from Changes in Geographic Variation and Socioeconomic Inequalities in Esophageal Cancer Mortality in China, 1973–2017
Supplementary Table 2 from Changes in Geographic Variation and Socioeconomic Inequalities in Esophageal Cancer Mortality in China, 1973–2017
Supplementary Table 3 from Changes in Geographic Variation and Socioeconomic Inequalities in Esophageal Cancer Mortality in China, 1973–2017
Supplementary Table 1 from Changes in Geographic Variation and Socioeconomic Inequalities in Esophageal Cancer Mortality in China, 1973–2017
Supplementary Figure 1 from Changes in Geographic Variation and Socioeconomic Inequalities in Esophageal Cancer Mortality in China, 1973–2017
Supplementary Figure 2 from Changes in Geographic Variation and Socioeconomic Inequalities in Esophageal Cancer Mortality in China, 1973–2017
Cancer incidence and mortality in China, 2022
Cancer incidence and mortality in China, 2022.
[Cancer incidence and mortality in China, 2022].
Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN.
Cancer survival statistics in China 2019–2021: a multicenter, population-based study
Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050.
Global esophageal cancer epidemiology in 2022 and predictions for 2050: A comprehensive analysis and projections based on GLOBOCAN data